RecruitingNCT07124741

Prognostic Power of the VEXUS Score in Septic Shock: Effectiveness in Mortality Prediction

Prognostic Power of the VEXUS Score in Septic Shock: Efficacy in Mortality Prediction


Sponsor

Antalya Training and Research Hospital

Enrollment

100 participants

Start Date

Mar 30, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to evaluate the prognostic power of the VEXUS Score in predicting mortality among patients with septic shock in intensive care units.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Age>18
  • Patients monitored for septic shock in intensive care unit
  • Signed informed consent

Exclusion Criteria9

  • Age <18
  • Severe obesity precluding adequate ultrasonographic imaging.
  • Patients in whom venous structures cannot be clearly assessed via ultrasonography due to anatomical or technical reasons (e.g., adhesions following abdominal surgery).
  • Patients receiving dialysis due to chronic kidney disease or initiating dialysis for acute kidney failure.
  • Chronic heart failure.
  • Patients with advanced valvular insufficiency or advanced pulmonary hypertension.
  • Patients with portal hypertension or advanced-stage liver cirrhosis.
  • Presence of acute or chronic thrombosis in the inferior vena cava or other venous structures within the scoring area.
  • Refusal to participate

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTSerial VEXUS Ultrasound Evaluation

Ultrasound assessments will be performed by an experienced anesthesiologist at three time points (0-4 hours, 12-24 hours, and 72 hours)to determine the degree of venous congestion using the VEXUS Score. No treatment changes will be made based on the VEXUS findings. The scores will solely be used for prognostic correlation with mortality outcomes.


Locations(1)

Antalya Training and Research Hospital

Antalya, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07124741


Related Trials